Edition:
United States

TRACON Pharmaceuticals Inc (TCON.OQ)

TCON.OQ on NASDAQ Stock Exchange Global Market

0.96USD
18 Jan 2019
Change (% chg)

$-0.10 (-9.43%)
Prev Close
$1.06
Open
$1.04
Day's High
$1.11
Day's Low
$0.92
Volume
108,460
Avg. Vol
41,889
52-wk High
$3.15
52-wk Low
$0.50

Chart for

About

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is... (more)

Overall

Beta: --
Market Cap(Mil.): $61.63
Shares Outstanding(Mil.): 16.66
Dividend: --
Yield (%): --

Financials

  TCON.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.76 -- --
ROI: -107.08 8.99 14.48
ROE: -146.37 10.13 15.99

Earnings vs. Estimates